These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 32235718)

  • 21. Standard therapies versus novel therapies in Hodgkin lymphoma.
    Gallamini A; Di Raimondo F; La Nasa G; Romano A; Borra A; Greco M
    Immunol Lett; 2013; 155(1-2):56-9. PubMed ID: 24140162
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exploration of differentially expressed plasma proteins in patients with lung adenocarcinoma using iTRAQ-coupled 2D LC-MS/MS.
    Li W; Zheng H; Qin H; Liu G; Ke L; Li Y; Li N; Zhong X
    Clin Respir J; 2018 Jun; 12(6):2036-2045. PubMed ID: 29363881
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Postoperative recurrence of epithelial ovarian cancer patients and chemoresistance related protein analyses.
    Zhang Z; Qin K; Zhang W; Yang B; Zhao C; Zhang X; Zhang F; Zhao L; Shan B
    J Ovarian Res; 2019 Mar; 12(1):29. PubMed ID: 30917846
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Proteomics analysis of Hodgkin lymphoma: identification of new players involved in the cross-talk between HRS cells and infiltrating lymphocytes.
    Ma Y; Visser L; Roelofsen H; de Vries M; Diepstra A; van Imhoff G; van der Wal T; Luinge M; Alvarez-Llamas G; Vos H; Poppema S; Vonk R; van den Berg A
    Blood; 2008 Feb; 111(4):2339-46. PubMed ID: 18070985
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of routine imaging in detecting recurrent lymphoma: A review of 258 patients with relapsed aggressive non-Hodgkin and Hodgkin lymphoma.
    El-Galaly TC; Mylam KJ; Bøgsted M; Brown P; Rossing M; Gang AO; Haglund A; Arboe B; Clausen MR; Jensen P; Pedersen M; Bukh A; Jensen BA; Poulsen CB; d'Amore F; Hutchings M
    Am J Hematol; 2014 Jun; 89(6):575-80. PubMed ID: 24493389
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chemoresistance can be overcome with high-dose chemotherapy and autologous stem-cell transplantation for relapsed and refractory Hodgkin lymphoma.
    Gerrie AS; Power MM; Shepherd JD; Savage KJ; Sehn LH; Connors JM
    Ann Oncol; 2014 Nov; 25(11):2218-2223. PubMed ID: 25149708
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preparation and Immunoaffinity Depletion of Fresh Frozen Tissue Homogenates for Mass Spectrometry-Based Proteomics in the Context of Drug Target/Biomarker Discovery.
    Prieto DA; Chan KC; Johann DJ; Ye X; Whitely G; Blonder J
    Methods Mol Biol; 2017; 1647():71-90. PubMed ID: 28808996
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Potential plasma biomarkers of bladder cancer identified by proteomic analysis: A pilot study.
    Lemańska-Perek A; Lis-Kuberka J; Lepczyński A; Dratwa-Chałupnik A; Tupikowski K; Kątnik-Prastowska I; Ożgo M
    Adv Clin Exp Med; 2019 Mar; 28(3):339-346. PubMed ID: 29963784
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Using Health Care Claims Data to Assess the Prevalence of Hodgkin Lymphoma and Relapsed or Refractory Hodgkin Lymphoma in the United States.
    Lin J; Siegartel LR; Lingohr-Smith M; Menges B; Makenbaeva D
    Clin Ther; 2017 Feb; 39(2):303-310. PubMed ID: 28065438
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The prognostic value of biological markers in paediatric Hodgkin lymphoma.
    Farruggia P; Puccio G; Sala A; Todesco A; Buffardi S; Garaventa A; Bottigliero G; Bianchi M; Zecca M; Locatelli F; Pession A; Pillon M; Favre C; D'Amico S; Provenzi M; Trizzino A; Zanazzo GA; Sau A; Santoro N; Murgia G; Casini T; Mascarin M; Burnelli R;
    Eur J Cancer; 2016 Jan; 52():33-40. PubMed ID: 26630532
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A targeted salvage therapy with Brentuximab vedotin in heavily treated refractory or relapsed pediatric Hodgkin lymphoma patients before and after stem cell transplantation.
    Taçyıldız N; Tanyıldız HG; Ünal E; Dinçaslan H; Asarcıklı F; Aksoy BA; Vatansever G; Yavuz G
    Turk J Pediatr; 2019; 61(5):671-676. PubMed ID: 32104998
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Higher dimensional (Hi-D) separation strategies dramatically improve the potential for cancer biomarker detection in serum and plasma.
    Hoffman SA; Joo WA; Echan LA; Speicher DW
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Apr; 849(1-2):43-52. PubMed ID: 17140865
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Proteomic profiling of pretreatment serum from HIV-infected patients identifies candidate markers predictive of lymphoma development.
    Vase MØ; Ludvigsen M; Bendix K; Hamilton-Dutoit S; Mller MB; Pedersen C; Pedersen G; Obel N; Larsen CS; d'Amore F; Honoré B
    AIDS; 2016 Jul; 30(12):1889-98. PubMed ID: 27177314
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic value of some inflammatory markers in patients with lymphoma.
    Hamed Anber N; El-Sebaie AH; Darwish NHE; Mousa SA; Shamaa SS
    Biosci Rep; 2019 Mar; 39(3):. PubMed ID: 30814315
    [No Abstract]   [Full Text] [Related]  

  • 35. Analysis of human serum by liquid chromatography-mass spectrometry: improved sample preparation and data analysis.
    Govorukhina NI; Reijmers TH; Nyangoma SO; van der Zee AG; Jansen RC; Bischoff R
    J Chromatogr A; 2006 Jul; 1120(1-2):142-50. PubMed ID: 16574134
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relapsed Hodgkin's lymphoma: immunostaining patterns in relation to survival.
    Amini RM; Enblad G; Engström P; Christensson B; Glimelius B; Sundström C
    Leuk Lymphoma; 2002 Jun; 43(6):1253-60. PubMed ID: 12152993
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasma biomarkers for detecting Hodgkin's lymphoma in HIV patients.
    Varnum SM; Webb-Robertson BJ; Hessol NA; Smith RD; Zangar RC
    PLoS One; 2011; 6(12):e29263. PubMed ID: 22195036
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High relapse rate in children with non-advanced nodular lymphocyte predominant Hodgkin's lymphoma (NLPHL or nodular paragranuloma) treated with chemotherapy only.
    van Grotel M; Lam KH; de Man R; Beishuizen A; Pieters R; van den Heuvel-Eibrink MM
    Leuk Lymphoma; 2006 Aug; 47(8):1504-10. PubMed ID: 16966260
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The proteomic advantage: label-free quantification of proteins expressed in bovine milk during experimentally induced coliform mastitis.
    Boehmer JL; DeGrasse JA; McFarland MA; Tall EA; Shefcheck KJ; Ward JL; Bannerman DD
    Vet Immunol Immunopathol; 2010 Dec; 138(4):252-66. PubMed ID: 21067814
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Outcome analysis of high-dose chemotherapy and autologous stem cell transplantation in adolescent and young adults with relapsed or refractory Hodgkin lymphoma.
    Akhtar S; Rauf SM; Elhassan TA; Maghfoor I
    Ann Hematol; 2016 Sep; 95(9):1521-35. PubMed ID: 27376363
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.